Lyssikatos Joseph P
CHIEF SCIENTIFIC OFFICER · 21 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-02-12 | ELVN | Enliven Therapeutics, Inc. | Award | 18,750 | $0.00 | $0.00 | filing |
| 2026-02-06 | ELVN | Enliven Therapeutics, Inc. | Sale | 5,000 | $29.04 | $145,219.00 | filing |
| 2026-01-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 14,509 | $26.90 | $390,284.85 | filing |
| 2026-01-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 5,491 | $26.37 | $144,814.14 | filing |
| 2026-01-09 | ELVN | Enliven Therapeutics, Inc. | Sale | 50,000 | $29.13 | $1.5M | filing |
| 2026-01-09 | ELVN | Enliven Therapeutics, Inc. | Sale | 41,198 | $24.90 | $1.0M | filing |
| 2026-01-08 | ELVN | Enliven Therapeutics, Inc. | Sale | 33,802 | $24.92 | $842,474.29 | filing |
| 2026-01-08 | ELVN | Enliven Therapeutics, Inc. | Sale | 7,500 | $20.13 | $150,961.50 | filing |
| 2025-12-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 5,000 | $16.84 | $84,206.00 | filing |
| 2025-11-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 12,008 | $22.30 | $267,794.01 | filing |
| 2025-11-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 492 | $23.09 | $11,360.77 | filing |
| 2025-10-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 12,500 | $22.08 | $276,025.00 | filing |
| 2025-09-26 | ELVN | Enliven Therapeutics, Inc. | Sale | 4,000 | $20.25 | $81,005.20 | filing |
| 2025-09-23 | ELVN | Enliven Therapeutics, Inc. | Sale | 1,500 | $20.03 | $30,045.00 | filing |
| 2025-09-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 4,870 | $19.11 | $93,063.27 | filing |
| 2025-09-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 2,130 | $20.02 | $42,634.08 | filing |
| 2025-08-21 | ELVN | Enliven Therapeutics, Inc. | Sale | 7,500 | $20.01 | $150,099.00 | filing |
| 2025-08-19 | ELVN | Enliven Therapeutics, Inc. | Sale | 5,000 | $19.62 | $98,117.50 | filing |
| 2025-07-21 | ELVN | Enliven Therapeutics, Inc. | Sale | 11,924 | $22.26 | $265,458.05 | filing |
| 2025-07-21 | ELVN | Enliven Therapeutics, Inc. | Sale | 576 | $22.90 | $13,187.75 | filing |
| 2025-06-20 | ELVN | Enliven Therapeutics, Inc. | Sale | 12,500 | $21.40 | $267,457.50 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.